{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses how the accumulation of mutant A53T -synuclein leads to compensatory effects that include the up-regulation of autophagy, which in turn leads to mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "The paper provides explicit statements about the disease mechanism (mitochondrial dysfunction caused by mutant -synuclein accumulation and autophagy up-regulation) that are relevant to the functional assay being described."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses a cell phenotype rescue assay to investigate the effects of mutant A53T -synuclein on mitochondrial function.",
          "judgment": "Yes",
          "reasoning": "A cell phenotype rescue assay effectively models or reflects the disease pathogenesis (mitochondrial dysfunction caused by mutant -synuclein accumulation) defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_number": "3a",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "sub_step_number": "3c",
              "questions": [
                {
                  "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "sub_step_number": "4a",
              "questions": [
                {
                  "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "sub_step_number": "4c",
              "questions": [
                {
                  "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                  "answer": "Not specified"
                },
                {
                  "question": "How was the OddsPath value calculated for this variant?",
                  "answer": "The paper provides an OddsPath value of >18.7 for mutant A53T -synuclein, indicating very strong evidence of pathogenicity."
                }
              ]
            }
          ]
        }
      ],
      "functional_evidence_strength": "PS3_very_strong"
    }
  ]
}